Retraction: MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition
Retraction

Retraction: MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition

Huabin Wang1#, Changmin Qi2#, Dan Wan3

1Department of Obstetrics and Gynecology, Eastern Hospital, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, China; 2Department of Cardiac Surgery Centre, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China; 3Department of Gynecology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China

#These authors contributed equally to this work as co-first author.

Correspondence to: Dan Wan. Department of Gynecology, Chongqing Hospital of Traditional Chinese Medicine, No. 6 Panxi Road Branch7, Jiangbei District, Chongqing 400021, China. Email: cywhb2020@163.com.

Submitted Aug 01, 2024. Accepted for publication Aug 14, 2024. Published online Oct 28, 2024.

doi: 10.21037/atm-2024-15


Retraction to: Ann Transl Med 2021;9:124.

The paper “MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition” (doi: 10.21037/atm-20-8027) published in Annals of Translational Medicine in Vol 9, No 2 (January 30, 2021) (1) has been retracted at the request of the authors.

Regrettably, the authors found a major error in the picture in this article. Specifically, images are used incorrectly, resulting in duplication of images in other articles. This error undermines the integrity and credibility of the work, and we believe it is necessary to correct this error as soon as possible.

Upon discovering this issue, we immediately conducted a thorough review of the manuscript and confirmed the inaccuracy of the picture. We understand that such errors can adversely affect the reputation of the scientific community and of journals. Therefore, we are taking proactive steps to correct the situation by requesting the removal of the published article. All authors agree with the retraction of the paper. We are sorry for the inconvenience caused.


Footnote

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-2024-15/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Wang H, Qi C, Wan D. MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition. Ann Transl Med 2021;9:124. [Crossref] [PubMed]
Cite this article as: Wang H, Qi C, Wan D. Retraction: MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition. Ann Transl Med 2025;13(3):36. doi: 10.21037/atm-2024-15

Download Citation